We only have this paper's title and publication details.
Read it at the sourceMechanisms behind hypogammaglobulinaemia during rituximab treatment are poorly understood.
No takes yet. Share an insight, caveat, or question.
Hallberg et al. (2024) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: